Skip to main content
SpringerLink
Log in

Idoxifene and Estradiol Enhance Antiapoptotic Activity Through Estrogen Receptor-β in Cultured Rat Hepatocytes

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Oxidative stress plays a causative role in the development of hepatic fibrosis and apoptosis. Estradiol (E2) is an antioxidant, and idoxifene is a tissue-specific selective estrogen-receptor modulator. We have previously demonstrated that E2 inhibits hepatic fibrosis in rat models of hepatic fibrosis and that the actions of E2 are mediated through estrogen receptors (ERs). This study reports on the antiapoptotic role of idoxifene and E2, and the functions of ER subtypes ER-α and ER-β in hepatocytes undergoing oxidative stress. Lipid peroxidation was induced in cultured rat hepatocytes with ferric nitrilotriacetate solution with idoxifene or E2. Oxidative stress-induced early apoptosis was linked to its ability to inhibit not only the expression of Bcl-2 and Bcl-XL but the production of antioxidant enzymes as well and to stimulate Bad expression. Hepatocytes possessed functional ER-β, but not ER-α, to respond directly to idoxifene and E2. Idoxifene and E2 suppressed oxidative stress-induced reactive oxygen species generation and lipid peroxidation, and their antiapoptotic effects on the activation of activator protein-1 and nuclear factor-κB, the loss of antioxidant enzyme activity, and Bcl-2 family protein expression in early apoptotic hepatocytes were blocked by the pure ER antagonist ICI 182,780. Our results indicate that idoxifene and E2 could enhance antiapoptotic activity through ER-β during oxidative damage in hepatocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shimizu I: Antifibrogenic therapies in chronic HCV infection. Curr Drug Targets-Infectious Disorders 1:227-240, 2001

    Google Scholar 

  2. Poynard T, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349:825-832, 1997

    Google Scholar 

  3. Shimizu I, Inoue H, Yano M, Shinomiya H, Wada S, Tsuji Y, Tsutsui A, Okamura S, Shibata H, Ito S: Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Liver 21:342-349, 2001

    Google Scholar 

  4. Yoshino K, Komura S, Watanabe I, Nakagawa Y, Yagi K: Effect of estrogens on serum and liver lipid peroxide levels in mice. J Clin Biochem Nutr 3:233-239, 1987

    Google Scholar 

  5. Lacort M, Leal AM, Liza M, Martin C, Martinez R, Ruiz-Larrea MB: Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids 30:141-146, 1995

    Google Scholar 

  6. Shimizu I: Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol 15:D84-D90, 2000

    Google Scholar 

  7. Shimizu I, Mizobuchi Y, Shiba M, Ma Y-R, Horie T, Liu F, Ito S: Inhibitory effect of estradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut 44:127-136, 1999

    Google Scholar 

  8. Yasuda M, Shimizu I, Shiba M, Ito S: Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 29:719-727, 1999

    Google Scholar 

  9. Omoya T, Shimizu I, Zhou Y, Okamura Y, Inoue H, Lu G, Itonaga M, Honda H, Nomura M, Ito S: Effects of idoxifene and estradiol on NF-κB activation in cultured rat hepatocytes undergoing oxidative stress. Liver 21:183-191, 2001

    Google Scholar 

  10. Shimizu I, Omoya T, Kondo Y, Kusaka Y, Tsutsui A, Shibata H, Honda H, Sano N, Ito S: Estrogen therapy in a male patient with chronic hepatitis C and irradiation-induced testicular dysfunction. Intern Med 40:100-104, 2001

    Google Scholar 

  11. Wang TT, Phang JM: Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55:2487-2489, 1995

    Google Scholar 

  12. Garcia-Segura LM, Cardona GP, Naftolin F, Chowen JA: Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport 9:593-597, 1998

    Google Scholar 

  13. Gohel A, McCarthy MB, Gronowicz G: Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 140:5339-5347, 1999

    Google Scholar 

  14. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251, 1993

    Google Scholar 

  15. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 351:1047-1059, 1997

    Google Scholar 

  16. Treinen KA, Rehm S, Wier PJ: An evaluation of the novel selective estrogen receptor modulator, idoxifene, for effects on reproduction in rats and rabbits. Toxicol Sci 41:199-207, 1998

    Google Scholar 

  17. Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M: Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Cancer Res 59:3646-3651, 1999

    Google Scholar 

  18. Nuttall ME, Bradbeer JN, Stroup GB, Nadeau DP, Hoffman SJ, Zhao H, Rehm S, Gowen M: Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats. Endocrinology 139:5224-5234, 1998

    Google Scholar 

  19. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME: Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res 83:224-229, 1998

    Google Scholar 

  20. Zhou Y, Shimizu I, Lu G, Itonaga M, Okamura Y, Shono M, Honda H, Inoue S, Muramatsu M, Ito S: Hepatic stellate cells contain the functional estrogen receptor β but not the estrogen receptor α in male and female rats. Biochem Biophys Res Commun 286:1059-1065, 2001

    Google Scholar 

  21. Wakeling AE, Bowler J: ICI 182,780, a new antioestrogen with clinical potential. J Steroid Biochem Mol Biol 43:173-177, 1992

    Google Scholar 

  22. Shimizu I, Ichihara A, Nakamura T: Hepatocyte growth factor in ascites from patients with cirrhosis. J Biochem 109:14-18, 1991

    Google Scholar 

  23. Shimizu I, Ma Y-R, Mizobuchi Y, Liu F, Miura T, Nakai Y, Yasuda M, Shiba M, Horie T, Amagaya S, Kawada N, Hori H, Ito S: Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29:149-160, 1999

    Google Scholar 

  24. Maxwell DP, Wang Y, McIntosh L: The alternative oxidase lowers mitochondrial reactive oxygen production in plant cells. Proc Natl Acad Sci USA 96:8271-8276, 1999

    Google Scholar 

  25. Koike S, Sakai M, Muramatsu M: Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res 15:2499-2513, 1987

    Google Scholar 

  26. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930, 1996

    Google Scholar 

  27. Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ: Hepatocytes in the bile duct-ligated rat express Bcl-2. Am J Physiol 272:G1587-G1593, 1997

    Google Scholar 

  28. Christensen JG, Gonzales AJ, Cattley RC, Goldsworthy TL: Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Differ 9:815-825, 1998

    Google Scholar 

  29. Rashid A, Wu TC, Huang CC, Chen CH, Lin HZ, Yang SQ, Lee FY, Diehl AM: Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29:1131-1138, 1999

    Google Scholar 

  30. Ray SD, Balasubramanian G, Bagchi D, Reddy CS: Ca2+-calmodulin antagonist chlorpromazine and poly(ADP-ribose) polymerase modulators 4-aminobenzamide and nicotinamide influence hepatic expression of BCL-XL and P53 and protect against acetaminophen-induced programmed and unprogrammed cell death in mice. Free Radic Biol Med 31:277-291, 2001

    Google Scholar 

  31. Haidara K, Morel I, Abalea V, Gascon BM, Denizeau F: Mechanism of tert-butylhydroperoxide induced apoptosis in rat hepatocytes: involvement of mitochondria and endoplasmic reticulum. Biochim Biophys Acta 1542:173-185, 2002

    Google Scholar 

  32. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545-1556, 1995

    Google Scholar 

  33. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510, 1997

    Google Scholar 

  34. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM: Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci USA 96:3999-4004, 1999

    Google Scholar 

  35. Alvaro D, Alpini G, Onori P, Perego L, Svegliata BG, Franchitto A, Baiocchi L, Glaser SS, Le Sage G, Folli F, Gaudio E: Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 119:1681-1691, 2000

    Google Scholar 

  36. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870, 1997

    Google Scholar 

  37. Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB: Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. J Clin Endocrinol Metab 82:3509-3512, 1997

    Google Scholar 

  38. Maruyama K, Endoh H, Sasaki-Iwaoka H, Kanou H, Shimaya E, Hashimoto S, Kato S, Kawashima H: A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action. Biochem Biophys Res Commun 246:142-147, 1998

    Google Scholar 

  39. Dickson RB, Eisenfeld AJ: 17 Alpha-ethinyl estradiol is more potent than estradiol in receptor interactions with isolated hepatic parenchymal cells. Endocrinology 108:1511-1518, 1981

    Google Scholar 

  40. Crabb DW, Roepke J: Loss of growth hormone-dependent characteristics of rat hepatocytes in culture. In Vitro Cell Dev Biol 23:303-307, 1987

    Google Scholar 

  41. Omoya T, Shimizu I, Liu F, Honda H, Ito S: Estradiol enhances biological defense activities against oxidative stress and prevents hepatic fibrosis. Hepatology 30:490A, 1999

    Google Scholar 

  42. Osborne MR, Hewer A, Davis W, Strain AJ, Keogh A, Hardcastle IR, Phillips DH: Idoxifene derivatives are less reactive to DNA than tamoxifen derivatives, both chemically and in human and rat liver cells. Carcinogenesis 20:293-297, 1999

    Google Scholar 

  43. Hard GC, Iatropoulos MJ, Jordan K, Radi L, Kaltenberg OP, Imondi AR, Williams GM: Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res 53:4534-4541, 1993

    Google Scholar 

  44. Fischer-Dzoga K, Wissler RW, Vesselinovitch D: The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp Mol Pathol 39:355-363, 1983

    Google Scholar 

  45. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW: Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 109:612-617, 1993

    Google Scholar 

  46. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan-TR J, Lubahn DB, O'Donnell-TF J, Korach KS, Mendelsohn ME: Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 3:545-548, 1997

    Google Scholar 

  47. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye JC: Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology 136:1523-1529, 1995

    Google Scholar 

Download references

Authors
  1. Hiroshi Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ichiro Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guangming Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mina Itonaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xuezhi Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshihito Okamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masayuki Shono
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hirohito Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Satoshi Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masami Muramatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Susumu Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inoue, H., Shimizu, I., Lu, G. et al. Idoxifene and Estradiol Enhance Antiapoptotic Activity Through Estrogen Receptor-β in Cultured Rat Hepatocytes. Dig Dis Sci 48, 570–580 (2003). https://doi.org/10.1023/A:1022553119715

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022553119715

Search

Navigation